{"id":5712,"date":"2020-03-31T17:30:09","date_gmt":"2020-03-31T16:30:09","guid":{"rendered":"https:\/\/www.ab-science.com\/?p=5712"},"modified":"2021-09-23T14:50:48","modified_gmt":"2021-09-23T13:50:48","slug":"la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001","status":"publish","type":"post","link":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/","title":{"rendered":"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]<\/p>\n<h3 class=\"Default\">31\/03\/2020 &#8211; AB Science annonce aujourd\u2019hui que la Food and Drug Administration (FDA) am\u00e9ricaine a autoris\u00e9 la demande d&rsquo;autorisation de conduire son \u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique<\/h3>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<iframe width=\"100%\" height=\"800\" src=\"https:\/\/www.ab-science.com\/themencode-pdf-viewer-sc\/?tnc_pvfw=ZmlsZT1odHRwczovL3d3dy5hYi1zY2llbmNlLmNvbS93cC1jb250ZW50L3VwbG9hZHMvMjAyMS8wOS8yMDIwLTAzLTMxX0FMU19JTkRfQ2xlYXJhbmNlX0ZSLnBkZiZzZXR0aW5ncz0xMTEwMTExMTExMTExMTExMTAwJmxhbmc9ZW4tVVM=#page=&zoom=100&pagemode=none\" title=\"\"><\/iframe>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">#default-btn-9b0c83c5fd1d10e58ee7842b08839c0b.ico-right-side > i {\n  margin-right: 0px;\n  margin-left: 8px;\n}\n#default-btn-9b0c83c5fd1d10e58ee7842b08839c0b > i {\n  margin-right: 8px;\n}<\/style><div class=\"btn-align-center\"><a href=\"https:\/\/www.ab-science.com\/wp-content\/uploads\/2021\/09\/2020-03-31_ALS_IND_Clearance_FR.pdf\" class=\"default-btn-shortcode dt-btn dt-btn-l link-hover-off \" target=\"_blank\" id=\"default-btn-9b0c83c5fd1d10e58ee7842b08839c0b\" rel=\"noopener\"><i class=\"dt-icon-the7-download\"><\/i><span>T\u00e9l\u00e9charger le PDF<\/span><\/a><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] 31\/03\/2020 &#8211; AB Science annonce aujourd\u2019hui que la Food and Drug Administration (FDA) am\u00e9ricaine a autoris\u00e9 la demande d&rsquo;autorisation de conduire son \u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[],"class_list":["post-5712","post","type-post","status-publish","format-standard","hentry","category-2020-fr","category-79","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La FDA a autoris\u00e9 la conduite de l&#039;\u00e9tude de phase 3 du masitinib<\/title>\n<meta name=\"description\" content=\"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l&#039;\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique\" \/>\n<meta property=\"og:description\" content=\"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l&#039;\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/\" \/>\n<meta property=\"og:site_name\" content=\"AB Science\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-31T16:30:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-23T13:50:48+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/a6488ccf78f6ce38f56db0bb7228ffa6\"},\"headline\":\"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique\",\"datePublished\":\"2020-03-31T16:30:09+00:00\",\"dateModified\":\"2021-09-23T13:50:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/\"},\"wordCount\":162,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"articleSection\":[\"2020\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/\",\"name\":\"La FDA a autoris\u00e9 la conduite de l'\u00e9tude de phase 3 du masitinib\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\"},\"datePublished\":\"2020-03-31T16:30:09+00:00\",\"dateModified\":\"2021-09-23T13:50:48+00:00\",\"description\":\"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l'\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"name\":\"AB Science\",\"description\":\"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#organization\",\"name\":\"AB Science\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"contentUrl\":\"https:\\\/\\\/www.ab-science.com\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/logo_ab-science-wh120.png\",\"width\":120,\"height\":120,\"caption\":\"AB Science\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ab-science\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/#\\\/schema\\\/person\\\/a6488ccf78f6ce38f56db0bb7228ffa6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/ab-science.excalibra.com\"],\"url\":\"https:\\\/\\\/www.ab-science.com\\\/fr\\\/author\\\/antoine_f6vzo0vn\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La FDA a autoris\u00e9 la conduite de l'\u00e9tude de phase 3 du masitinib","description":"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l'\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/","og_locale":"fr_FR","og_type":"article","og_title":"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique","og_description":"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l'\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique","og_url":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/","og_site_name":"AB Science","article_published_time":"2020-03-31T16:30:09+00:00","article_modified_time":"2021-09-23T13:50:48+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/#article","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/"},"author":{"name":"admin","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/a6488ccf78f6ce38f56db0bb7228ffa6"},"headline":"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique","datePublished":"2020-03-31T16:30:09+00:00","dateModified":"2021-09-23T13:50:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/"},"wordCount":162,"publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"articleSection":["2020"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/","url":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/","name":"La FDA a autoris\u00e9 la conduite de l'\u00e9tude de phase 3 du masitinib","isPartOf":{"@id":"https:\/\/www.ab-science.com\/fr\/#website"},"datePublished":"2020-03-31T16:30:09+00:00","dateModified":"2021-09-23T13:50:48+00:00","description":"La FDA a autoris\u00e9 la demande d\u2019autorisation de conduire l'\u00e9tude de phase 3 du masitinib (AB19001) dans la scl\u00e9rose lat\u00e9rale amyotrophique","breadcrumb":{"@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ab-science.com\/fr\/la-food-and-drug-administration-fda-americaine-autorise-conduite-etude-de-phase-3-masitinib-ab19001\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.ab-science.com\/fr\/"},{"@type":"ListItem","position":2,"name":"La FDA autorise le recrutement de patients aux USA dans l\u2019\u00e9tude de phase 3 du masitinib dans la Scl\u00e9rose Lat\u00e9rale Amyotrophique"}]},{"@type":"WebSite","@id":"https:\/\/www.ab-science.com\/fr\/#website","url":"https:\/\/www.ab-science.com\/fr\/","name":"AB Science","description":"Masitinib and AB8939 \u2013 Two compounds with breakthrough mechanism of action","publisher":{"@id":"https:\/\/www.ab-science.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ab-science.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ab-science.com\/fr\/#organization","name":"AB Science","url":"https:\/\/www.ab-science.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","contentUrl":"https:\/\/www.ab-science.com\/wp-content\/uploads\/2020\/11\/logo_ab-science-wh120.png","width":120,"height":120,"caption":"AB Science"},"image":{"@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/ab-science\/"]},{"@type":"Person","@id":"https:\/\/www.ab-science.com\/fr\/#\/schema\/person\/a6488ccf78f6ce38f56db0bb7228ffa6","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/37434bc9f38884ed0b9fe0f34bc67ecc3858ae54e6ff3d90e3c112864996eca0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/ab-science.excalibra.com"],"url":"https:\/\/www.ab-science.com\/fr\/author\/antoine_f6vzo0vn\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/5712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/comments?post=5712"}],"version-history":[{"count":0,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/posts\/5712\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/media?parent=5712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/categories?post=5712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ab-science.com\/fr\/wp-json\/wp\/v2\/tags?post=5712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}